Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (1979)	12/13/2007 10:22:28 AM
From: Jibacoa	Read Replies (2) \| Respond to of 3722

MATK Opened with an UG & is up 12.86% in spite of the general market. bigcharts.marketwatch.com MATK said yesterday that its 4thQ income rose $18.3M, or $0.55/shr, from $100,000, or less than $0.01/shr, in 2006.(The results included a $10.8M tax benefit.) The revenue for the 4thQ rose more than 22% to $82M from $67.2M in 2006. The stock seems to want to get back to the $30 level, but the general market isn't helping.<g> bigcharts.marketwatch.com MATK's life'sDHA brand supplements are an excellent source of DHA omega-3,containing an all-natural, vegetarian source of DHA, so you get the benefits of DHA without the worry of ocean-borne pollutants and toxins potentially found in certain fish. The product is manufactured in an FDA-inspected facility with controls in place to ensure the highest quality & contains 200mg of DHA. A smaller, easier to swallow capsule containing 100mg of DHA is available for kids over the age of six. For possible benefits of DHA supplements, look at data on Wikipedia:<g> en.wikipedia.org Bernard